Evidence map›Paper›PMID 40613212›Full record

ReviewInternational journal of oncology2025

The role of abnormal epigenetic regulation of small GTPases in glioma (Review).

Mingyang Zhang, Yimin Huang, Qiang Zhang, Xiaoyan Zhang, Lumei Kang, Jianguo Wang

Abstract readReview
In one paragraph

Review in International journal of oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Mingyang ZhangDepartment of Histology and Embryology, Medical College, Nanchang University, Nanchang, Jiangxi 330006, P.R. China.
Yimin HuangDepartment of Central Laboratory, Jiaxing Women and Children's Hospital, Wenzhou Medical University, Jiaxing, Zhejiang 314000, P.R. China.
Qiang ZhangDepartment of Clinical Laboratory, Longgang District People's Hospital of Shenzhen, Shenzhen, Guangdong 518172, P.R. China.
Xiaoyan ZhangDepartment of Central Laboratory, Jiaxing Women and Children's Hospital, Wenzhou Medical University, Jiaxing, Zhejiang 314000, P.R. China.
Lumei KangDepartment of Medical Experimental Teaching Center, School of Basic Medical Sciences, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi 330006, P.R. China.
Jianguo WangDepartment of Central Laboratory, Jiaxing Women and Children's Hospital, Wenzhou Medical University, Jiaxing, Zhejiang 314000, P.R. China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Brain tumors are one of the most severe types of malignant tumors and glioma accounts for ~80% of malignant brain tumors. The current treatment methods for glioma are limited and patients with glioma often experience relapse following treatment, which leads to a poor prognosis for these patients. Therefore, novel therapeutic targets and methods urgently need to be explored. The present review screened studies that mainly focused on the epigenetic regulation of small guanosine triphosphate (GTP)ase in glioma. These small GTPases participate in most cellular biological processes, including differentiation, proliferation, cell migration, apoptosis, vesicle and organelle dynamics and transport, nuclear dynamics and cytoskeleton regulation. Due to the diversity and importance of the biological functions of small GTPases, an increasing number of studies have focused on them; however, the incidence of changes in the gene structure of small GTPases is considered to be low in glioma. Several studies have shown that the abnormal expression of genes encoding small GTPases is often influenced by epigenetic regulation in glioma. Epigenetic regulation is a dynamic and reversible process, which implies that the reversal of abnormal epigenetic modifications is a potential treatment strategy for glioma. These previous studies, which are summarized in the present review, not only provide new therapeutic targets and prognostic markers, but also provide information regarding the treatment of glioma. The current review may provide valuable insights for future research and promote the clinical translation of relevant research results.

Indexed as

Brain NeoplasmsEpigenesis, GeneticGliomaMonomeric GTP-Binding ProteinsDNA MethylationGene Expression Regulation, NeoplasticHumansPrognosisMonomeric GTP-Binding ProteinsDNA methylationepigenetic regulationgliomahistone post‑translational modificationsnon‑coding RNAsmall GTPase

Identifiers

PMID40613212
PMCPMC12272223

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.